Organon (OGN) Depreciation & Amortization (CF) (2020 - 2026)

Organon (OGN) has reported Depreciation & Amortization (CF) for 7 consecutive years, with $39.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Depreciation & Amortization (CF) rose 14.71% year-over-year to $39.0 million; the TTM figure through Mar 2026 stood at $161.0 million (up 20.15% YoY), while the FY2025 annual figure was $156.0 million, up 18.18% from the prior year.
• Depreciation & Amortization (CF) came in at $39.0 million for Q1 2026 at Organon, down from $46.0 million in the prior quarter.
• The five-year high for Depreciation & Amortization (CF) was $46.0 million in Q4 2025, with the low at $22.0 million in Q2 2022.
• Average Depreciation & Amortization (CF) over 5 years is $31.9 million, with a median of $32.0 million recorded in 2023.
• The largest YoY upside for Depreciation & Amortization (CF) was 38.89% in 2022 against a maximum downside of 14.29% in 2022.
• Year by year, Depreciation & Amortization (CF) stood at $24.0 million in 2022, then surged by 33.33% to $32.0 million in 2023, then rose by 6.25% to $34.0 million in 2024, then jumped by 35.29% to $46.0 million in 2025, then retreated by 15.22% to $39.0 million in 2026.
• According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $39.0 million, $46.0 million, and $40.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.